.png)
The event kicks off with a welcome reception on the 5th. The following day, the 6th, features two major sessions: one focusing on new methods for analyzing placebo effects in CNS trials, and the other on digital prescriptions for CNS disorders. A poster session and reception will also take place. The final day, the 7th, includes a session questioning the relevance of clinician-rated psychopathology measures in today's context, as well as concurrent working groups tackling challenges in orphan disease trials, trial designs for psychedelics, and accelerating the development of psychopathology measures.
Read more and register here.